Logo

2015 Vol.33, N°4 - Suppl.91 - Table of contents

Scleroderma 2015Title: Scleroderma 2015

Guest Editor: S. Bombardieri

Purchase all articles

PageArticle - [Author(s)]PDFAbs.
One year in review

CER8791
2015,33,4,Suppl.91
Pg. 0003-0014

Systemic sclerosis: a critical digest of the recent literature
S. Barsotti, C. Stagnaro, A. Della Rossa › Free to View
Rheumatology ArticleRheumatology Abstract
Etiopathogenesis

CER8157
2015,33,4,Suppl.91
Pg. 0015-0022

Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model
Ö. Pamuk, G. Can, S. Ayvaz, T. Karaca, G. Pamuk, S. Demirtas, G. Tsokos
Rheumatology ArticleRheumatology Abstract
Clinical aspects

CER7906
2015,33,4,Suppl.91
Pg. 0023-0025

Prospective evaluation of frequency of signs of systemic sclerosis in 76 patients with morphea
D. Lipsker, D. Bessis, A. Cosnes, N. Kluger, V. Lutz, E. Sauleau, C. Francès
Rheumatology ArticleRheumatology Abstract
 

CER7392
2015,33,4,Suppl.91
Pg. 0026-0030

Factors influencing the occupational trajectory of patients with systemic sclerosis: a qualitative study
S. Decuman, V. Smith, M. Grypdonck, F. De Keyser, S. Verhaeghe
Rheumatology Article
Rheumatology Article
Rheumatology Abstract
 

CER8166
2015,33,4,Suppl.91
Pg. 0031-0035

Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
E. Ochoa, J. Martin, S. Assasi, L. Beretta, P. Carreira, A. Guillén, C. Simeón, E. Koumakis, P. Dieude, Y. Allanore, F. García-Hernández, G. Espinosa, I. Castellví, J. Trapiella, L. Rodriguez, M. González-Gay, M. Egurbide, L. Sáez, J. Callejas-Rubio, J. Vargas-Hitos, N. Hunzelmann, G. Riemekasten, T. Witte, J. Distler, A. Kreuter, C. Lunardi, A. Santaniello, F. Tan, P. Shiels, A. Herrick, J. Worthington, M. Vonk, B. Koeleman, T. Radstake, M. Mayes, J. Martin, A. the Spanish Scleroderma Group
Rheumatology ArticleRheumatology Abstract
 

CER8310
2015,33,4,Suppl.91
Pg. 0036-0039

Increased messenger RNA levels of the mesenchymal cadherin-11 in the peripheral blood of systemic sclerosis patients correlate with diffuse skin involvement
P. Christopoulos, V. Bournia, S. Panopoulos, A. Vaiopoulos, M. Koutsilieris, P. Sfikakis
Rheumatology ArticleRheumatology Abstract
 

CER7876
2015,33,4,Suppl.91
Pg. 0040-0046

A comparison between general rheumatologists and scleroderma experts with respect to following systemic sclerosis guidelines
J. Reed, J. Pope
Rheumatology ArticleRheumatology Abstract
 

CER8055
2015,33,4,Suppl.91
Pg. 0047-0054

An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database
M. Brand, R. Hollaender, D. Rosenberg, M. Scott, E. Hunsche, A. Tyndall, V. Denaro, P. Carreira, C. Varju, B. Gabrielli, S. Zingarelli, P. Caramaschi, K. Simic-Pasalic, U. Müller Ladner, M. Vasile, C. Mihai, E. Rosato, A. Vacca, T. Zenone, W. Mohamed, C. Ancuta, G. Zampogna, S. Rednic, N. Jabaar, L. Belloli, M. Pozzi, R. Foti, U. Walker, A. EUSTAR Co-investigators
Rheumatology ArticleRheumatology Abstract
 

CER8405
2015,33,4,Suppl.91
Pg. 0055-0060

Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis
R. Gualtierotti, F. Ingegnoli, R. Two, P. Meroni, D. Khanna, A. study group VERITAS
Rheumatology ArticleRheumatology Abstract
 

CER8654
2015,33,4,Suppl.91
Pg. 0061-0067

A Romanian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument
M. Gorga, C. Mihai, A. Soare, R. Dobrota, A. Gherghe, V. Stoica
Rheumatology ArticleRheumatology Abstract
 

CER8517
2015,33,4,Suppl.91
Pg. 0068-0074

Disease duration and Medsger’s severity score are associated with significant liver fibrosis in patients with systemic sclerosis
S. Lee, B. Kim, J. Park, D. Kim, S. Ahn, J. Song, Y. Park, S. Lee, K. Han, S. Kim
Rheumatology ArticleRheumatology Abstract
 

CER8639
2015,33,4,Suppl.91
Pg. 0075-0079

Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database
B. Sandmeier, V. Jäger, G. Nagy, P. Carreira, A. Tzankov, M. Widuchowska, M. Antic, O. Distler, H. Reichert, J. Distler, U. Walker, T. Hügle
Rheumatology ArticleRheumatology Abstract
Diagnosis

CER7724
2015,33,4,Suppl.91
Pg. 0080-0086

Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis
G. Guarnieri, E. Zanatta, P. Mason, M. Scarpa, E. Pigatto, P. Maestrelli, F. Cozzi
Rheumatology ArticleRheumatology Abstract
 

CER7434
2015,33,4,Suppl.91
Pg. 0087-0091

Sonographic assessment of interstitial lung disease in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus
F. Moazedi-Fuerst, S. Kielhauser, K. Brickmann, N. Tripolt, M. Meilinger, A. Lufti, W. Graninger
Rheumatology ArticleRheumatology Abstract
 

CER7957
2015,33,4,Suppl.91
Pg. 0092-0097

The relationship between nailfold capillaroscopic assessment and telangiectasia score with severity of peripheral vascular involvement in systemic sclerosis
Y. Yalcinkaya, O. Pehlivan, A. Omma, N. Alpay, B. Erer, S. Kamali, L. Ocal, M. Inanc
Rheumatology ArticleRheumatology Abstract
 

CER7976
2015,33,4,Suppl.91
Pg. 0098-0105

Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis
C. Corallo, L. Paulesu, M. Cutolo, F. Ietta, C. Carotenuto, C. Mannelli, R. Romagnoli, R. Nuti, N. Giordano
Rheumatology ArticleRheumatology Abstract
 

CER7760
2015,33,4,Suppl.91
Pg. 0106-0110

Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China
S. Zhang, D. Xu, M. Li, Y. Hou, Q. Wang, Z. Tian, Y. Liu, X. Guo, J. Lai, J. Zhao, C. Hu, N. Song, Q. Sun, F. Zhang, Y. Zhao, X. Zeng
Rheumatology ArticleRheumatology Abstract
 

CER8009
2015,33,4,Suppl.91
Pg. 0111-0116

Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease
O. Moore, S. Proudman, N. Goh, T. Corte, H. Rouse, O. Hennessy, K. Morrisroe, V. Thakkar, J. Sahhar, J. Roddy, P. Youssef, E. Gabbay, P. Nash, J. Zochling, W. Stevens, M. Nikpour
Rheumatology ArticleRheumatology Abstract
 

CER8163
2015,33,4,Suppl.91
Pg. 0117-0122

What tests should you use to assess small intestinal bacterial overgrowth in systemic sclerosis?
Y. Braun-Moscovici, M. Braun, D. Khanna, A. Balbir-Gurman, D. Furst
Rheumatology ArticleRheumatology Abstract
 

CER8229
2015,33,4,Suppl.91
Pg. 0123-0126

Pilot study to determine whether transient receptor potential melastatin type 8 (TRPM8) antibodies are detected in scleroderma
A. Shah, J. Montagne, S. Oh, F. Wigley, L. Casciola-Rosen
Rheumatology ArticleRheumatology Abstract
 

CER8448
2015,33,4,Suppl.91
Pg. 0127-0130

Predictive value of vascular disease biomarkers for digital ulcers in systemic sclerosis patients
I. Silva, A. Teixeira, J. Oliveira, I. Almeida, R. Almeida, C. Vasconcelos
Rheumatology Article
Rheumatology Article
Rheumatology Abstract
 

CER8458
2015,33,4,Suppl.91
Pg. 0131-0135

Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival
M. Wodkowski, M. Hudson, S. Proudman, J. Walker, W. Stevens, M. Nikpour, S. Assassi, M. Mayes, M. Wang, M. Baron, M. Fritzler, A. the Canadian Scleroderma Research Group, A. the Australian Scleroderma Cohort Study, A. the Genetics versus Environment in Scleroderma Outcome Study
Rheumatology ArticleRheumatology Abstract
 

CER8563
2015,33,4,Suppl.91
Pg. 0136-0141

Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome.
I. Pinal-Fernandez, E. Pallisa-Nuñez, A. Selva-O´Callaghan, E. Castella-Fierro, C. Simeon-Aznar, V. Fonollosa-Pla, M. Vilardell-Tarres
Rheumatology ArticleRheumatology Abstract
 

CER8574
2015,33,4,Suppl.91
Pg. 0142-0147

Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease
M. Rizzi, P. Sarzi-Puttini, A. Airoldi, M. Antivalle, M. Battellino, F. Atzeni
Rheumatology ArticleRheumatology Abstract
Treatment

CER8088
2015,33,4,Suppl.91
Pg. 0148-0152

Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study
E. Romano, S. Bellando-Randone, M. Manetti, C. Bruni, G. Lepri, M. Matucci-Cerinic, S. Guiducci
Rheumatology ArticleRheumatology Abstract
 

CER8158
2015,33,4,Suppl.91
Pg. 0153-0159

Content of non-pharmacological care for systemic sclerosis and educational needs of European health professionals: a EUSHNet survey
L. Willems, A. Redmond, T. Stamm, C. Boström, S. Decuman, A. Tyrrell Kennedy, J. Brozd, S. Roškar, V. Smith, T. Vliet Vlieland, C. van den Ende
Rheumatology Article
Rheumatology Article
Rheumatology Abstract
 

CER8677
2015,33,4,Suppl.91
Pg. 0160-0167

Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab
P. Fraticelli, S. De Vita, N. Franzolini, S. Svegliati, C. Scott, C. Tonnini, T. Spadoni, B. Gabrielli, G. Pomponio, G. Moroncini, A. Gabrielli
Rheumatology ArticleRheumatology Abstract
Case Report

CER7715
2015,33,4,Suppl.91
Pg. 0168-0170

Intravenous immunogobulin therapy for severe gastrointestinal involvement in systemic sclerosis
K. Clark, O. Etomi, C. Denton, V. Ong, C. Murray
Rheumatology ArticleRheumatology Abstract
 

CER7435
2015,33,4,Suppl.91
Pg. 0171-0174

Scleroderma renal crisis as an initial presentation of systemic sclerosis: a case report and review of the literature
K. Logee, S. Lakshminarayanan
Rheumatology ArticleRheumatology Abstract
 

CER8350
2015,33,4,Suppl.91
Pg. 0175-0178

Tumoral calcinosis of the spine in the course of systemic sclerosis: report of a new case and review of the literature
D. Sambataro, G. Sambataro, E. Zaccara, W. Maglione, C. Vitali, N. Del Papa
Rheumatology ArticleRheumatology Abstract
 

CER8499
2015,33,4,Suppl.91
Pg. 0179-0181

Protective role of interleukin-6 in systemic sclerosis gastrointestinal tract involvement: case report and review of the literature
T. Frech, M. Hudson
Rheumatology ArticleRheumatology Abstract
Review

CER8462
2015,33,4,Suppl.91
Pg. 0182-0189

Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients
N. Giordano, A. Montella, C. Corallo, G. Ruocco, C. Chirico, A. Palazzuoli, R. Nuti, G. Pecetti
Rheumatology ArticleRheumatology Abstract
 

CER8588
2015,33,4,Suppl.91
Pg. 0190-0194

Disease-related malnutrition in systemic sclerosis: evidences and implications
V. Codullo, E. Cereda, G. Crepaldi, S. Cappello, C. Montecucco, R. Caccialanza, R. Caporali
Rheumatology ArticleRheumatology Abstract
Letters to the Editor

CER8419
2015,33,4,Suppl.91
Pg. 0195

Capillaroscopic patterns in systemic sclerosis: do we need a “stable” pattern?
P. Clemente-Coelho
Rheumatology ArticleRheumatology Abstract
 

CER8386
2015,33,4,Suppl.91
Pg. 0196

Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan
M. Sebastiani, A. Manfredi, V. Cestelli, E. Praino, F. Cannarile, D. Giuggioli, M. Colaci, C. Ferri
Rheumatology ArticleRheumatology Abstract
 

CER8130
2015,33,4,Suppl.91
Pg. 0197-0198

The antifibrotic role of hepatocyte growth factor in dermal fibroblasts of systemic sclerosis
H. Cao, T. Dou, J. Yang, J. Jing, M. Zheng, X. Man
Rheumatology ArticleRheumatology Abstract